Correction: Protection against N. gonorrhoeae induced by OMV-based meningococcal vaccines are associated with cross-species directed humoral and cellular immune responses

• Weiyan Zhu,
• Andreea Waltmann,
• Marguerite B. Little,
• Kristie L. Connolly,
• Kathryn A. Matthias,
• Keena S. Thomas,
• Mary C. Gray,
• Aleksandra E. Sikora,
• Aleksandra E. Sikora,
• Alison K. Criss,
• Margaret C. Bash,
• Andrew N. Macintyre,
• Ann E. Jerse,
• Joseph A. Duncan,
• Joseph A. Duncan

Affiliations

Weiyan Zhu

Division of Infectious Diseases, University of North Carolina School of Medicine, Chapel Hill, NC, United States

Andreea Waltmann

Division of Infectious Diseases, University of North Carolina School of Medicine, Chapel Hill, NC, United States

Marguerite B. Little

Department of Pharmacology, University of North Carolina School of Medicine, Chapel Hill, NC, United States

Kristie L. Connolly

Department of Microbiology and Immunology, Uniformed Services University, Bethesda, MD, United States

Kathryn A. Matthias

Laboratory of Bacterial Polysaccharides, Division of Bacterial, Parasitic, and Allergenic Products, Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, United States

Keena S. Thomas

Department of Microbiology, Immunology, and Cancer Biology, University of Virginia, Charlottesville, VA, United States

Mary C. Gray

Department of Microbiology, Immunology, and Cancer Biology, University of Virginia, Charlottesville, VA, United States

Aleksandra E. Sikora

Department of Pharmaceutical Sciences, College of Pharmacy, Oregon State University, Corvallis, OR, United States

Aleksandra E. Sikora

Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, OR, United States

Alison K. Criss

Department of Microbiology, Immunology, and Cancer Biology, University of Virginia, Charlottesville, VA, United States

Margaret C. Bash

Laboratory of Bacterial Polysaccharides, Division of Bacterial, Parasitic, and Allergenic Products, Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, United States

Andrew N. Macintyre

Department of Medicine, Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, United States

Ann E. Jerse

Department of Microbiology and Immunology, Uniformed Services University, Bethesda, MD, United States

Joseph A. Duncan

Division of Infectious Diseases, University of North Carolina School of Medicine, Chapel Hill, NC, United States

Joseph A. Duncan

Department of Pharmacology, University of North Carolina School of Medicine, Chapel Hill, NC, United States